U.S. Food and Drug Administration

A new study has warned that declining childhood vaccination rates in the United States could trigger a dramatic resurgence of diseases that were eradicated years ago. What Happened: On Sunday, former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb shared a study on X...

The U.S. Food and Drug Administration (FDA) may approve updated COVID-19 vaccines this week to combat recent strains as the country endures its most significant summer outbreak in two years. The FDA is expected to give the nod to updated mRNA vaccines from Moderna, Inc. (NASDAQ:MRNA) and Pfizer Inc...

Three Key Takeaways: FDA Nods to MDMA Therapy Application: The FDA has accepted Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, marking a significant step in recognizing psychedelic therapies’ medical potential. A Milestone in Psychedelic Research: This development...

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE: CYBN) and UK-based Small Pharma Inc. (OTCMKTS: DMTTF) held their respective annual general and special shareholders meetings on October 12. They announced that...

Cannabis researcher MMJ International Holdings Corp recently reached a milestone when it officially submitted requested responses to the U.S. Food and Drug Administration (FDA) regarding its cannabis formulation. This submission comes in response to an FDA notification...

"This is a big deal," says Boris Jordan, founder and executive chairman of the board of Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), referring to the recent recommendation by the Health and Human Services Department (HHS) to the Drug Enforcement Administration (...

A bipartisan group of senators, including Mark Warner (D-VA), Bob Casey (D-PA), Bill Cassidy (R-LA), Marco Rubio (R-FL) and Bill Hagerty (R-TN), have pinpointed state-level marijuana legalization as a disruptor to international drug cartels. These senators, while not direct proponents of...

The U.S. Food and Drug Administration (FDA) has initiated public input regarding the potential international control of certain drugs, a move preceding the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) meeting in October. Highlighted in the Federal Register, the FDA...

As debates around potential post-traumatic stress disorder (PTSD) treatments continue, the use of cannabis and its derivatives has come under increased scrutiny. Despite claims of effectiveness, key stakeholders such as the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD)...

In a recent interview at the Benzinga Cannabis Capital Conference in Miami, Kris Krane, cannabis industry consultant and director of cannabis development for KCSA Strategic Communications, stressed the crucial focus on the presidential administration this year. The founder of 4Front Ventures Corp...

In the realm of healthcare advocacy, two organizations have joined forces to battle a shared adversary: unregulated CBD. What Happened: "Our utmost goal is to help individuals living with chronic diseases and serious injuries that cause pain improve their quality of life and have better health...

"We're not going to stand by as bad actors are profiting off the sale of illegal products that are addicting our nation's youth," declared Brian King, director of the FDA's Tobacco Center, signaling a new era of regulatory action against the vaping industry....

To protect children from inadvertently consuming cannabis-infused snacks, the U.S. Federal Trade Commission (FTC) and Food and Drug Administration (FDA) sent cease and desist letters to six marijuana companies. "Children are more vulnerable than adults to the effects of THC, with many who...

President Joe Biden's Juneteenth proclamation signaled a potential shift in cannabis policy. Biden stressed his commitment to marijuana reform, including last October's pardons for federal cannabis prisoners and a comprehensive review of its legal classification....

The U.S. Department of Health and Human Services (HHS) is working to complete an administrative review of cannabis scheduling and aims to present President Joe Biden with a federal cannabis scheduling decision "this year," according to the head of the HHS Secretary Xavier Becerra,...